Results 11 to 20 of about 157,710 (222)

A Case of Childhood Lupus Anticoagulant-Hypoprothrombinemia Syndrome with Diagnostic and Therapeutic Insight [PDF]

Pediatric Health, Medicine and Therapeutics
Bi Zhou,1,* Wanyan Jiao,2,* Ying Li,1,* Yuanyuan Hou,1,* Feng Zhu,1 Xiao Yang1 1Department of Pediatrics, Suzhou Hospital of Anhui Medical University, Suzhou, Anhui, People’s Republic of China; 2Department of Pediatric ...
Zhou B, Jiao W, Li Y, Hou Y, Zhu F, Yang X   +5 more
doaj   +4 more sources

Lupus anticoagulant hypoprothrombinemia syndrome: A case report [PDF]

Clinical Case Reports, 2023
Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare entity associated with an increased risk of hemorrhage. Corticosteroids have been used in its treatment with favorable results.
Natalia Acedo, Alejandro Alonso, Eliana Samantha Feijoó, Cristina García, Ana M. Ortiz, Adrián Alegre   +5 more
doaj   +3 more sources

Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association [PDF]

Thrombosis Journal
Background Lupus anticoagulant (LA) is an in vitro phenomenon with prolongation of a phospholipid-dependent coagulation test which is not due to an inhibitor specific to a coagulation factor.
Ting Hon Stanford Li, Pui Lun Yip, Hui Yiu Chan, Ho Kin Stephen Chan, Wai Shan Wong   +4 more
doaj   +3 more sources

Successful treatment of lupus anticoagulant hypoprothrombinemia syndrome with rituximab [PDF]

Thrombosis Journal, 2023
Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare acquired bleeding disorder secondary to development of antibodies against prothrombin protein, in the presence of antiphospholipid antibodies.
Sanober Nusrat, Sayani Tewari, Osman Khan   +2 more
doaj   +3 more sources

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing [PDF]

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli, Arianna Gatti, Flora Ierna, Elena Riccardi, Irene Cuppari   +4 more
wiley   +2 more sources

Clinical features and treatment of 70 children with lupus anticoagulant-hypoprothrombinemia syndrome: a retrospective study from a single center in China [PDF]

Research and Practice in Thrombosis and Haemostasis
Background: Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is a rare acquired bleeding disorder characterized by the presence of lupus anticoagulant (LA) and acquired hypoprothrombinemia.
Dandan Tian, Junfeng Zhang, Jintu Lou, Xuejun Chen, Juan Liang, Xiaojun Xu, Hui Gao, Wenjian Nie, Qing Ye, Hongqiang Shen   +9 more
doaj   +2 more sources

Lupus anticoagulant hypoprothrombinemia syndrome associated with a hemorrhagic ovarian cyst in a girl with systemic lupus erythematosus : a case report [PDF]

Childhood Kidney Diseases
Lupus anticoagulant hypoprothrombinemia syndrome (LAHPS) is a rare entity characterized by the presence of lupus anticoagulant (LA) and prothrombin (factor II) deficiency. It may cause severe bleeding contrary to classical antiphospholipid syndrome. Here,
Min Hwa Son, Hyung Eun Yim
doaj   +2 more sources

Lupus anticoagulant and mortality in patients hospitalized for COVID-19 [PDF]

, 2021
Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant ...
Malinverni L., Gazzaruso C., Ravetto C., Tondelli E., Cerrone M., Altavilla T., Mariani G., Sala V., Gallotti P., Bevilacqua L., Coppola A.   +10 more
core   +1 more source

Lupus anticoagulant in systemic lupus erythematosus and its association with complications [PDF]

, 2022
Background: The anti-phospholipid antibody which can occur secondary to SLE have a broad spectrum of both thrombotic and non-thrombotic manifestations.
Irshad Ali K. M., Ali K. M., Irshad, S. Raj, Silpa, Anju C. K., S., Sankar, Silpa S. Raj, C. K., Anju, Sankar S.   +7 more
core   +1 more source

Anti-phospholipid-antibodies in patients with relapsing polychondritis [PDF]

, 1998
Relapsing polychondritis (RP) is an extremly rare multisystemic disease thought to be of autoimmune origin. In order to assess if RP is associated with anti-phospholipid antibodies (aPL), clinical data and sera of 21 patients with RP were collected in a ...
Schlosser, U., Schmitz, G., Lang, B., Zeuner, M., Straub, R. H., Rauh, G., Schòlmerich, J.   +6 more
core   +1 more source